BETA: Please send your feedback!
Toll Brothers
TOL:NYS
Homebuilding
$5.03bn
MID cap
$34.95
(-1.05%)
0.05%
since start of 2019
7.35
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 2007
Eagle Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Bruce E. Toll | Vice Chairman | Male |
| Robert I. Toll | Executive Chairman | Male |
| Douglas C. Yearley, Jr. | Chief Executive Officer, Director & EVP | Male |
| Frederick N. Cooper | SVP-Finance, International Development & IR | Male |
| Martin P. Connor, CPA | Chief Financial Officer | Male |
| Gregg L. Ziegler, MBA | Treasurer & Senior Vice President | Male |
| Jonathan C. Downs | Senior Vice President-Human Resources | Male |
| John K. McDonald | Chief Compliance Officer, SVP & General Counsel | Male |
| Richard T. Hartman | President, Chief Operating Officer & Director | Male |
| John Critikos | Chief Information Officer & Senior Vice President | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Eagle Pharmaceuticals - Competitors and Related Companies
How Eagle Pharmaceuticals stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Eagle Pharmaceuticals
EGRX:NAS
Pharmaceuticals: Other
—
SMALL cap
$55.69
(—)
—
since start of 2019
—
Loading…